USPTO serial 76346188
ISOGENIS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JENKINS JR, CHARLES L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ISOGENIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anastasia Khokhryakova
ANASTASIA KHOKHRYAKOVA COUDERT BROTHERS1627 I ST NWWASHINGTON, DC 20006-4007UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and bioengineering reagents, protein receptors, gene therapy vectors, chemical preparations in the form of receptors, DNA sequences, DNA variations, and cells, all used for scientific, laboratory or medical research in the fields of gene therapy, genetic disorders, genetic engineering and bioengineering, auto immune diseases, stem cell research, tissue and organ transplantation, namely, prevention of transplant rejection; biological preparations, namely, recombinant vectors for laboratories, diagnostics, and analytics for scientific or research use; auxiliary preparations, carriers and substances for use in the manufacture of pharmaceutical preparations | ACTIVE | — |
| 005 | Pharmaceutical, medical and therapeutic products, namely, medicaments, pharmaceutical preparations and gene therapy vectors for the treatment of and use in gene therapy, genetic disorders, auto immune diseases; pharmaceutical, medical and therapeutic products, namely, medicaments, pharmaceutical preparations and gene therapy vectors for the treatment of and use in stem cell transplatation for humans, tissue and organ transplantation, namely, prevention of transplant rejection; auxiliary preparations, carriers and substances sold as integral components of pharmaceutical preparations and gene therapy vectors | ACTIVE | — |
| 042 | Medical and scientific research and product research all in the fields of gene therapy, genetic disorders, auto immune diseases, stem cell and organ transplantation, namely, prevention of transplant rejection | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Isogenis, Inc.
- Other trademarks owned by Isogenis, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ISOGENIS
- Prosecution event ABN6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 16, 2004 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 13, 2004 | CFIT | CASE FILE IN TICRS | — |
| Jan 16, 2004 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 11, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 11, 2003 | PAPER RECEIVED | — | |
| Jul 8, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 15, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 26, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 24, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 13, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 7, 2002 | ZZZY | PREVIOUS ACTION COUNT WITHDRAWN | — |
| Oct 2, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 21, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 25, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |